Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Replay partners with MD Anderson’s Katy Rezvani, heads to clinic with new TCR NK cell company
3 years ago
Financing
Cell/Gene Tx
Third time’s the charm: Cerevance’s Series B expands again
3 years ago
Financing
IPO Friday: Hypertension drugmaker Mineralys maps out $192M Nasdaq debut
3 years ago
Financing
As clinical trials get more complex, software startup Faro bags $20M to help visualize them
3 years ago
Financing
Outsourcing
Blood stem cell therapy maker Garuda nabs $62M
3 years ago
Financing
Cell/Gene Tx
Epilepsy and Alzheimer's cell therapy biotech lays off 25% of staff
3 years ago
People
Parthenon Therapeutics CEO exits weeks after co-founder leaves
3 years ago
People
'Moonshot' at liver cell therapy biotech Ambys Medicines comes to an end
3 years ago
People
Cell/Gene Tx
Vector BioMed launches with $15M to produce backlogged CAR-T component
3 years ago
Financing
Pharma
Small Nebraska startup hopes to challenge Pfizer, Merck in pneumococcal vaccine race
3 years ago
R&D
New York City invests $20M into biotech 'innovation space' at the Brooklyn Navy Yard
3 years ago
R&D
Kidney disease drugmaker Goldfinch Bio shuts down
3 years ago
People
Profluent debuts to design proteins with machine learning in bid to move past 'AI sprinkled on top'
3 years ago
Financing
AI
Investor 'misalignment' leads to tRNA biotech's shuttering
3 years ago
People
Grey Wolf reels in $49M to enter the clinic for new immunotherapy target
3 years ago
Financing
Neuralink employees cite layoffs at Elon Musk’s brain-computer interface startup
3 years ago
People
AI
Former DeepMind intern launches Atomic AI to 'parse' RNA structure for new small molecules
3 years ago
Financing
AI
‘Siloing is just so outdated’: New $350M VC fund aims to digitize life sciences
3 years ago
Financing
After hypertension competitor gets bought, Mineralys lines up IPO plans
3 years ago
Financing
Off Editas’ shelves, iNK cell therapies float to Shoreline
3 years ago
Deals
Cell/Gene Tx
Amgen extends autoimmune pact with small Michigan biotech
3 years ago
Deals
Pharma
Ex-US Commerce Secretary Wilbur Ross pairs his SPAC with Alzheimer's biotech
3 years ago
Deals
Diagnostics
Leap Therapeutics jumps into growing Claudin18.2 field by buying Flame Biosciences
3 years ago
Financing
Deals
Scoop: Roche-backed startup gives up on CD47, lays off all employees
3 years ago
People
First page
Previous page
32
33
34
35
36
37
38
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit